Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05388032 · ClinicalTrials.gov registry record · NA
Sodium Lowering Vascular Effects Trial
A NA study of Endothelial Dysfunction and Vascular Stiffness, sponsored by Tulane University.
- Recruiting
- Registry status
- NA
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT05388032: Recruiting NA study of Endothelial Dysfunction and Vascular Stiffness, sponsored by Tulane University.
NCT05388032 is a NA study of Endothelial Dysfunction and Vascular Stiffness that is actively recruiting participants, run by Tulane University. The registered enrollment target is 256 participants, above the 87-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (194% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05388032, a NA study of Endothelial Dysfunction and Vascular Stiffness, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed mechanistic trial will test the effect of dietary sodium reduction on cardiac and vascular structure and function in those with elevated blood pressure or hypertension. Findings from this study will fill the knowledge gap on the underlying mechanisms of dietary sodium intake on cardiovascular disease risk in addition to blood pressure and could provide further evidence on sodium reduction for the prevention of cardiovascular disease.
Primary Outcome
Cardiac magnetic resonance imaging will be used to determine LVGLS.
Conditions Studied
Interventions
- BEHAVIORAL Sodium Reduction Intervention
Study Locations (1)
Louisiana
- Tulane University Office of Health Research - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05388032 shows while recruiting
NCT05388032 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, above the 87-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (194% higher).
The record links to 4 conditions, with Endothelial Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Sodium Reduction Intervention is the first listed.
NCT05388032 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05388032 about?
NCT05388032 is a clinical study titled "Sodium Lowering Vascular Effects Trial". The proposed mechanistic trial will test the effect of dietary sodium reduction on cardiac and vascular structure and function in those with elevated blood pressure or hypertension. Findings from this study will fill the knowledge gap on the underlying mechanisms of dietary sodium intake on cardiova...
What is the current status of trial NCT05388032?
This trial is currently recruiting. It is a NA study. The enrollment target is 256 participants. The study started on 2023-01-25. Estimated completion is 2026-12-31.
What conditions does trial NCT05388032 study?
This clinical trial studies the following conditions: Endothelial Dysfunction, Vascular Stiffness, Left Ventricular Dysfunction, Left Ventricular Hypertrophy.
What interventions are being tested in trial NCT05388032?
The interventions under investigation include: Sodium Reduction Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05388032?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05388032 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endothelial Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05388032's enrollment target sits among peer trials
256 3rd of 45 higher than 43 of 45 other Endothelial Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endothelial Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
ACEs, SIRT1, and Premature Vascular Aging in Humans
RECRUITING · NA
-
NightWare and Cardiovascular Health in Veterans With PTSD
RECRUITING · NA
-
Bright Light Exposure in Surgical Patients
RECRUITING · NA
-
Microvascular Dysfunction in Obesity
RECRUITING · NA
-
Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With "Standard of Care" Aerobic Exercise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI